Published in J Acquir Immune Defic Syndr on November 01, 2007
Informal care and reciprocity of support are associated with HAART adherence among men in Baltimore, MD, USA. AIDS Behav (2011) 1.38
Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review. AIDS (2012) 1.18
An introduction to family-centred services for children affected by HIV and AIDS. J Int AIDS Soc (2010) 1.17
Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors. AIDS Patient Care STDS (2010) 1.12
Social network approaches to recruitment, HIV prevention, medical care, and medication adherence. J Acquir Immune Defic Syndr (2013) 1.12
Main partner factors associated with worse adherence to HAART among women in Baltimore, Maryland: a preliminary study. AIDS Care (2011) 1.03
Gender, empowerment, and health: what is it? How does it work? J Acquir Immune Defic Syndr (2009) 0.98
Patients' perspectives on informal caregiver involvement in HIV health care appointments. AIDS Patient Care STDS (2009) 0.93
Patient-nominated, community-based HIV treatment supporters: patient perspectives, feasibility, challenges, and factors for success in HIV-infected South African adults. AIDS Patient Care STDS (2013) 0.93
Patient demographic and health factors associated with frequent use of emergency medical services in a midsized city. Acad Emerg Med (2013) 0.87
Social networks of substance users with HIV infection: application of the Norbeck Social Support Scale. West J Nurs Res (2011) 0.85
Health care provider perspectives on informal supporters' involvement in HIV care. Qual Health Res (2011) 0.82
Factors associated with high transmission risk and detectable plasma HIV RNA in HIV-infected MSM on ART. Int J STD AIDS (2014) 0.80
Informal HIV Caregiver Proxy Reports of Care Recipients' Treatment Adherence: Relationship Factors Associated with Concordance with Recipients' Viral Suppression. AIDS Behav (2015) 0.77
Informal Caregiver Characteristics Associated with Viral Load Suppression Among Current or Former Injection Drug Users Living with HIV/AIDS. AIDS Behav (2015) 0.76
Emotional social support and access to care among older people living with HIV in rural China. Int J Geriatr Psychiatry (2015) 0.75
Caregivers' Support Network Characteristics Associated with Viral Suppression among HIV Care Recipients. AIDS Behav (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med (2002) 5.30
Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS (2006) 5.21
Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA (2006) 4.51
Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med (2004) 4.38
Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr (2006) 3.93
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS (2007) 3.58
Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. AIDS (2005) 3.47
A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS (2002) 3.41
Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav (2006) 3.18
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry (2011) 3.15
Hospitalist care and length of stay in patients requiring complex discharge planning and close clinical monitoring. Arch Intern Med (2007) 3.07
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry. Lancet (2013) 2.82
Desire for children and pregnancy risk behavior among HIV-infected men and women in Uganda. AIDS Behav (2006) 2.59
Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health (2006) 2.42
Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med (2004) 2.37
Caregiver health literacy and the use of child health services. Pediatrics (2007) 2.23
A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS Behav (2012) 2.10
Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav (2006) 2.01
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr (2011) 1.97
Race/ethnic disparities in HIV testing and knowledge about treatment for HIV/AIDS: United States, 2001. AIDS Patient Care STDS (2004) 1.84
Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr (2007) 1.82
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis (2005) 1.80
Providers' experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med (2009) 1.78
Meta-analysis of cognitive-behavioral interventions on HIV-positive persons' mental health and immune functioning. Health Psychol (2008) 1.73
Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice. J Acquir Immune Defic Syndr (2006) 1.73
Longer lengths of stay and higher risk of mortality among inpatients of physicians with more years in practice. Am J Med (2011) 1.70
Medical homes: challenges in translating theory into practice. Med Care (2009) 1.69
Home buprenorphine/naloxone induction in primary care. J Gen Intern Med (2008) 1.67
Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial. Drug Alcohol Depend (2010) 1.67
Predicting HIV transmission risk among HIV-infected patients seen in clinical settings. AIDS Behav (2007) 1.62
Detecting an association between socioeconomic status and late stage breast cancer using spatial analysis and area-based measures. Cancer Epidemiol Biomarkers Prev (2007) 1.61
Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics (2006) 1.59
Living with HIV but without medical care: barriers to engagement. AIDS Patient Care STDS (2007) 1.59
Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol (2005) 1.58
A randomized trial of a multicomponent cessation strategy for emergency department smokers. Acad Emerg Med (2011) 1.55
Health services utilization for people with HIV infection: comparison of a population targeted for outreach with the U.S. population in care. Med Care (2006) 1.55
Medicaid patients at high risk for frequent hospital admission: real-time identification and remediable risks. J Urban Health (2008) 1.52
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users. J Acquir Immune Defic Syndr (2007) 1.48
CDC consultation on methamphetamine use and sexual risk behavior for HIV/STD infection: summary and suggestions. Public Health Rep (2006) 1.47
Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med (2008) 1.46
Interpreting the association between HIV and bone mineral density. AIDS (2007) 1.43
Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. Clin Infect Dis (2005) 1.41
Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. J Subst Abuse Treat (2008) 1.40
Sexual risk, substance use, and psychological distress in HIV-positive gay and bisexual men who also inject drugs. AIDS (2005) 1.36
Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. J Acquir Immune Defic Syndr (2006) 1.35
Teaching about Substance Abuse with Objective Structured Clinical Exams. J Gen Intern Med (2006) 1.34
Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev (2007) 1.33
HIV serostatus disclosure to sexual partners among HIV-positive injection drug users. AIDS Patient Care STDS (2004) 1.33
Partner awareness of the serostatus of HIV-seropositive men who have sex with men: impact on unprotected sexual behavior. AIDS Behav (2005) 1.30
A rationale and model for addressing tobacco dependence in substance abuse treatment. Subst Abuse Treat Prev Policy (2006) 1.30
Correlates of lending needles/syringes among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr (2007) 1.30
Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J (2008) 1.29
The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention. Clin Infect Dis (2006) 1.28
Menopause symptoms in HIV-infected and drug-using women. Menopause (2005) 1.27
Implementation of HIV prevention interventions with people living with HIV/AIDS in clinical settings: challenges and lessons learned. AIDS Behav (2007) 1.26
A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr (2012) 1.26
Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J Acquir Immune Defic Syndr (2004) 1.25
Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother (2005) 1.25
Proteinuria in children infected with the human immunodeficiency virus. J Pediatr (2008) 1.24
HIV infection, drug use, and onset of natural menopause. Clin Infect Dis (2005) 1.24
Correlates of risk patterns and race/ethnicity among HIV-positive men who have sex with men. AIDS Behav (2007) 1.24
Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.24
An intervention to reduce HIV risk behavior of substance-using men who have sex with men: a two-group randomized trial with a nonrandomized third group. PLoS Med (2010) 1.23
Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS (2007) 1.22
The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone. J Subst Abuse Treat (2005) 1.22
Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis (2005) 1.22
Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr (2004) 1.21
Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol (2011) 1.21
Initial strategies for integrating buprenorphine into HIV care settings in the United States. Clin Infect Dis (2006) 1.19
Advancing novel HIV prevention intervention research with MSM--meeting report. Public Health Rep (2011) 1.16
Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic Review. Prog Pediatr Cardiol (2007) 1.14
Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis (2002) 1.14
MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav (2013) 1.14
Comparison of antiretroviral adherence questions. AIDS Behav (2012) 1.14
Accuracy of self-reported smoking and secondhand smoke exposure in the US workforce: the National Health and Nutrition Examination Surveys. J Occup Environ Med (2008) 1.14
Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics. Contemp Clin Trials (2009) 1.13
Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Educ Prev (2004) 1.12